BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,000 | -83.8% | 10,750 | -72.5% | 0.00% | – |
| Q2 2019 | $68,000 | -50.7% | 39,070 | -3.6% | 0.00% | -100.0% |
| Q1 2019 | $138,000 | +26.6% | 40,520 | +4.9% | 0.00% | 0.0% |
| Q4 2018 | $109,000 | -68.7% | 38,620 | -32.3% | 0.00% | -66.7% |
| Q3 2018 | $348,000 | -25.0% | 57,020 | -9.1% | 0.00% | -25.0% |
| Q2 2018 | $464,000 | +23.7% | 62,745 | +9.9% | 0.00% | +33.3% |
| Q1 2018 | $375,000 | +18.3% | 57,110 | +31.1% | 0.00% | 0.0% |
| Q4 2017 | $317,000 | -26.3% | 43,550 | +18.7% | 0.00% | -25.0% |
| Q3 2017 | $430,000 | -4.0% | 36,700 | -3.4% | 0.00% | 0.0% |
| Q2 2017 | $448,000 | – | 38,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 22,374 | $105,000 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |